Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(5 sites)
Taiwan
Taichung Veterans General Hospital, Taichung National Cheng Kung University Hospital, Tainan National Taiwan University Hospital, Taipei Taipei Medical Univresity Hospital, Taipei Chang Gung Memorial Hospital, Linkou, Taoyuan District